ACKR3 and central nervous system cancer: Atypical Chemokine Receptor 3 (ACKR3, formerly CXCR7) is a β-arrestin-biased chemokine receptor1 that lacks detectable G protein activation in most cell types (with the exception of primary rodent astrocytes and human glioma cells)1–3.